Dermatoscope Market Estimated To Witness High Growth Owing To Rising Demand for Telermatology
by The Dermatoscope Market is estimated to be valued at US$ 951.1 Mn in 2023 and is expected to exhibit a CAGR of 12.% over the …
Category: Healthcare
Increased prevalence of diabetes is projected to boost the growth of insulin glargine market
The global insulin glargine market is estimated to be valued at US$ 6178.14 Mn in 2023 and is expected to exhibit a CAGR of 0.2% …
Projected Rise In Prevalence Of Eosinophilic Esophagitis To Drive Growth In The Global Eosinophilic Esophagitis Market
Market Overview: Eosinophilic Esophagitis is a chronic inflammatory disorder of the esophagus characterized by elevated numbers of eosinophils in the esophagus. The disease causes symptoms …
Chronic Aspergillosis Treatment Market Growth Probability, Leading Vendors and Future Scenario up to 2030
The global Chronic Aspergillosis Treatment Market is estimated to be valued at US$ 3.21 Bn in 2023 and is expected to exhibit a CAGR of 5.0% over …
The New Avenue For Biopharmaceutical CMO And CRO Market
Market Overview: Biopharmaceutical contract manufacturing organizations (CMOs) and contract research organizations (CROs) provide specialized services like drug development, manufacturing and analytical testing to pharmaceutical companies. …
Ontogenetic Market Size, Analysis, Competitive Strategies and Forecasts, 2023-2030
The global Ontogenetic Market is estimated to be valued at US$ 567.3 Mn in 2023 and is expected to exhibit a CAGR of 4.2% over the forecast …
Rapid adoption of non-invasive treatment alternatives to propel growth of the global High Intensity Focused Ultrasound (HIFU) market
The global High Intensity Focused Ultrasound (HIFU) Market is estimated to be valued at US$ 112.7 Mn in 2023 and is expected to exhibit a …
Antiepileptic Drugs Market High Growth Opportunities, Emerging Trends, Industry Review, Forecast Till 2030
The global Antiepileptic Drugs Market is estimated to be valued at US$7.01 Bn in 2023 and is expected to exhibit a CAGR of 3.3% over …